JNJ vs AMGN
By Alex · Tickerpine
Johnson & Johnson vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | AMGN |
|---|---|---|
| Price | $263.81 | $439.26 |
| Market cap | $635.07B | $237.48B |
| P/E ratio | 40.0 | 27.3 |
| ROE | 20.02% | 91.47% |
| Profit margin | 16.20% | 22.95% |
| Revenue growth | 5.90% | 9.50% |
| Dividend yield | 2.03% | 2.29% |
| Beta | 0.21 | 0.41 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs AMGN in plain English
- JNJ is the bigger company — about 2.7× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 27.3 vs 40.0).
- AMGN earns a higher return on equity (91% vs 20%).
- AMGN is growing revenue faster (10% vs 6%).
- AMGN has the higher dividend yield (2.29% vs 2.03%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.